Connecting academic expertise with industry need
CMAC is shaping the future of medicine manufacturing through collaboration. We work with leading academic institutions, technology innovators, global pharmaceutical companies, and key stakeholders to co-create transformative solutions.
41
Partners
20
Countries
10+
Projects
Tier 1 Partners
Together with our Tier One global pharma partners, we are delivering our strategy through a portfolio of collaborative, precompetitive research, translation and skills projects, driving innovation and impact across the medicines manufacturing landscape.
Name
Partner company
“Quote from T2I Quote from T2I Quote from T2I Quote from T2I Quote from T2I Quote from T2I Quote from T2I”
Name
Partner company
“Quote from T1 Quote from T1 Quote from T1 Quote from T1 Quote from T1 Quote from T1 Quote from T1 Quote from T1”
Translation to Industry Partners
We collaborate with leading CDMOs and tech vendors to accelerate CMC innovation, combining expertise in crystallisation, PAT, and digitisation with CMAC’s facilities to deliver integrated, efficient solutions for advanced medicines manufacturing.
Tier 2 Partners
Our Tier Two community is a dynamic network spanning digital technologies, data analytics, advanced manufacturing, consultancy, and specialised CROs, each bringing unique expertise to support shared goals through formal collaboration.
Name
Partner company
“Quote from T2 Quote from T2 Quote from T2 Quote from T2 Quote from T2 Quote from T2 Quote from T2”
Industry Members
CMAC has always benefited from strong industry engagement and leadership. An industry led membership organisation was created in 2011 and this has grown and developed over the years. The membership organisation operates under a pre-competitive, collaborative research and development model with senior level company support.
Academic Partners
Our academic partners are leading universities and research institutions that work with us to advance cutting-edge research, whilst sharing expertise and developing solutions that shape the future of medicines.
Collaborators
CMAC works closely with industry, government, regulators and the third-sector to align research, policy, and practice to accelerate innovation, ensure regulatory confidence and deliver impact across the full value chain.
